arrow
R

Reisa A. Sperling

Harvard Medical School
H指数:151
被引数:11.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Blood-based circular RNAs for early diagnosis of Alzheimer’s disease

基于血液的环状rna用于阿尔茨海默病的早期诊断

2026-07-010
OAAI
Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adults

血浆磷酸化tau蛋白217与认知正常老年人中Aβ、tau和认知能力的纵向轨迹

2026-04-140
OAAI
Genetic modifiers of APOE-ε4-associated cognitive decline

APOE-ε4相关认知衰退的遗传修饰因子

2026-02-200
OA
APOE, ABCA7, and RASGEF1C are associated with earlier onset of amyloid deposition from more than 4000 harmonized positron emission tomography images

APOE、ABCA7和RASGEF1C与超过4000例标准化正电子发射断层扫描图像中淀粉样蛋白沉积的更早发病相关。

2025-12-130
OAAI
Associations of lifestyle factors with amyloid pathology in persons without dementia

生活方式因素与无痴呆人群淀粉样蛋白病理的相关性

2025-11-130
OA
Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease

身体活动作为临床前期阿尔茨海默病的可改变风险因素

2025-11-030
OAAI
Using memory recall response time on digital cognitive testing to detect subtle cognitive changes among cognitively unimpaired older adults

利用数字认知测试中的记忆回忆反应时间,以检测认知功能正常的老年人中微妙的认知变化

2025-10-280
OAAI
Tau biology, biomarkers, and therapeutics

Tau生物学、生物标志物和治疗学

2025-10-210
OAAI
Modernizing diagnosis of Alzheimer's disease: A review of global trends and Asia-specific perspectives

阿尔茨海默病诊断的现代化:全球趋势及亚洲特定视角的综述

2025-08-040
OAAI
Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer's disease

常染色体显性阿尔茨海默病杏仁核亚区域的Tau-PET病理学及其与认知表现和神经精神症状的关系

2025-03-200
OA
CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET
2024-09-200
OAAI